Abstract:PURPOSE:To prospectively determine the prevalence of pulmonary embolism ( PE pulmonary embolism ) and renal vein thrombosis ( RVT renal vein thrombosis ) with computed tomography (CT) and to identify markers predictive of PE pulmonary embolism and/or RVT renal vein thrombosis in a large consecutive cohort of patients with nephrotic syndrome.MATERIALS AND METHODS:This study was approved by the local institutional review board, and all patients or their guardians provided written informed consent. Consecutive patients with nephrotic syndrome (24-hour urine protein > 3.5 g) underwent combined CT pulmonary angiography for PE pulmonary embolism and renal CT venography for RVT renal vein thrombosis . Prevalence of PE pulmonary embolism and/or RVT renal vein thrombosis was estimated for different ages, sexes, and histopathologic types of nephrotic syndrome. Multivariate analysis was used to determine independent predictors for PE pulmonary embolism and/or RVT renal vein thrombosis in patients with nephrotic syndrome.RESULTS:There were 512 patients in the study cohort (331 male patients, 181 female patients; mean age, 37 years ± 17 [standard deviation]; range, 9-81 years), including 80 children. One hundred eighty (35%) of 512 patients had PE pulmonary embolism and/or RVT renal vein thrombosis , with PE pulmonary embolism the more common condition (85% [153 of 180]). PE pulmonary embolism was associated with RVT renal vein thrombosis in 85 (56%) of 153 patients and was isolated in 68 patients (44%). Most patients with PE pulmonary embolism (84% [128 of 153]) were asymptomatic. One hundred twelve (22%) of 505 patients had RVT renal vein thrombosis . PE pulmonary embolism and/or RVT renal vein thrombosis was found in 15 (19%) of 80 children with nephrotic syndrome, while 165 (38%) of 432 adult patients with nephrotic syndrome had PE pulmonary embolism and/or RVT renal vein thrombosis (P = .001). Membranous nephropathy was the most common histopathologic type associated with PE pulmonary embolism and/or RVT renal vein thrombosis (48% [88 of 183]). Membranous nephropathy, age greater than 60 years, high hemoglobin level, long prothrombin time, and high creatinine level were independent predictors of PE pulmonary embolism and/or RVT renal vein thrombosis (P < .05 for all).CONCLUSION:PE pulmonary embolism and RVT renal vein thrombosis are common in patients with nephrotic syndrome. PE pulmonary embolism is more common than RVT renal vein thrombosis , is most often asymptomatic, and is most frequently found in patients with membranous nephropathy. A high index of suspicion and a low threshold for diagnostic work-up is warranted in these patients.

Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study.

Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome

Membranous Nephropathy: Pathogenesis and Treatments

Antiphospholipid Antibodies in Patients with Membranous Nephropathy.

Risk Factors of Pulmonary Thrombosis/Embolism in Nephrotic Syndrome

Risk factors of pulmonary thrombosis/embolism in nephrotic syndrome.

Mechanism and Treatment of Coagulation Disorder in Membranous Nephropathy

Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome

The risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels: a study over 10 years

Incidence of Venous Thromboembolism in Patients with Nephrotic Syndrome Based Upon Combined Dual Energy Pulmonary and Renal CT Angiography

Pulmonary Embolism and Renal Vein Thrombosis in Patients with Nephrotic Syndrome: Prospective Evaluation of Prevalence and Risk Factors with CT.

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy

Optimization of Combined CT Pulmonary Angiography and Renal Venography for the Detection of Venous Thromboembolism in Patients with Nephrotic Syndrome

Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy

The Clinicopathological Features of Patients with Membranous Nephropathy

Characterization of Thromboelastography of Patients with Different Pathological Types of Nephrotic Syndrome

The Application of Podocyte Antigen PLA2R and Anti-Pla2r Antibody in the Diagnosis and Treatment of Membranous Nephropathy

A glimpse of the glomerular milieu: from endothelial cell to thrombotic disease in nephrotic syndrome.

The Association of Syndecan-1, Hypercoagulable State and Thrombosis and in Patients with Nephrotic Syndrome.

Multiple Venous and Pulmonary Artery Thrombosis as a Presenting Complaint of Nephrotic Syndrome-Case Report and Challenges in Management

Novel Biomarkers in Membranous Nephropathy